Abstract |
Successful field oral vaccination and protection against viral diseases have so far been achieved only with live-attenuated or live-recombinant virus vaccines. In this communication, we present data that demonstrate that a glycoprotein derived from recombinant baculovirus-infected insect cells is efficacious as an oral vaccine. The glycoprotein (G) of rabies virus (Evelyn Rokitnicki Abelseth strain) was abundantly expressed in a baculovirus expression system and oral vaccination of racoons with the baculovirus-expressed G protein resulted in the production of rabies virus- neutralizing antibodies and protection against a lethal challenge with a street rabies virus. The potential for using the baculovirus-expressed G protein for oral immunization of wildlife is discussed.
|
Authors | Z F Fu, C E Rupprecht, B Dietzschold, P Saikumar, H S Niu, I Babka, W H Wunner, H Koprowski |
Journal | Vaccine
(Vaccine)
Vol. 11
Issue 9
Pg. 925-8
( 1993)
ISSN: 0264-410X [Print] Netherlands |
PMID | 8212838
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Viral
- Antigens, Viral
- Glycoproteins
- Rabies Vaccines
- Recombinant Fusion Proteins
- Vaccines, Synthetic
- Viral Envelope Proteins
- glycoprotein G, Rabies virus
|
Topics |
- Administration, Oral
- Animals
- Antibodies, Viral
(biosynthesis, immunology)
- Antigens, Viral
- Baculoviridae
- Cells, Cultured
- Cricetinae
- Glycoproteins
(administration & dosage, immunology)
- Kidney
- Mesocricetus
- Moths
- Rabies
(prevention & control)
- Rabies Vaccines
(administration & dosage, immunology)
- Rabies virus
(immunology)
- Raccoons
(immunology)
- Recombinant Fusion Proteins
(immunology)
- Vaccination
(methods, veterinary)
- Vaccines, Synthetic
(administration & dosage, immunology)
- Viral Envelope Proteins
(administration & dosage, immunology)
|